Mental Health Outcomes of Adults With Comorbidity and Chronic Diseases During the Covid-19 Pandemic: A Matched Case-Control Study

Guadagno, Silvia; Balestrieri, Matteo; Albert, Umberto; Maso, E.; Castelpietra, Giulio

doi:10.24869/psyd.2020.491

Cited by 69 publications

(79 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Louvardi et al [26] revealed that the anxiety and depression levels of individuals with chronic diseases were no different from the healthy control group. In other studies conducted during the pandemic period, individuals with chronic diseases had higher levels of depression, anxiety, and stress, and especially young chronic patients were affected more [27][28]. Supporting the findings of Ozamiz-Etxebarria et al [27] and Sayeed et al [28], we observed that the perceived stress, health anxiety, depression, and anxiety levels of individuals with chronic diseases were higher than the healthy group.…”

Section: Discussionsupporting

confidence: 89%

“…In other studies conducted during the pandemic period, individuals with chronic diseases had higher levels of depression, anxiety, and stress, and especially young chronic patients were affected more [27][28]. Supporting the findings of Ozamiz-Etxebarria et al [27] and Sayeed et al [28], we observed that the perceived stress, health anxiety, depression, and anxiety levels of individuals with chronic diseases were higher than the healthy group. Contrary to the study conducted by Bergman et al [29], which suggests that elderly individuals experience more health anxiety during the pandemic process and supporting that conducted by Ozamiz-Etxebarria et al [27], we found that perceived stress, health anxiety, and depression levels were inversely correlated with patient age and disease duration.…”

Section: Discussionsupporting

confidence: 89%

“…Studies investigating the psychosocial status of individuals with chronic diseases during the COVID-19 pandemic process were examined in the literature [26][27][28][29][30]. Louvardi et al [26] revealed that the anxiety and depression levels of individuals with chronic diseases were no different from the healthy control group.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Perceived stress level and health anxiety during COVID-19 pandemic period in patients with diabetes mellitus and hypertension: A prospective cross-sectional study

Bozkurt¹,

Gürsoy²,

Atay³

et al. 2021

Journal of Surgery and Medicine

View full text Add to dashboard Cite

Background/Aim: Mortality rates of Coronavirus Disease 2019 are increased in patients with chronic diseases such as diabetes mellitus (DM) and hypertension (HT). For this reason, some restrictions and lockdown measures were brought to these patients during the pandemic period, which may have disrupted their mental wellbeing. We aimed to investigate the relationship between the changes in the frequency of admissions of patients with DM, HT, DM+HT to the hospital during the pandemic and their perceived stress, health anxiety, general anxiety, and depression levels, and the change in stress burden experienced by disease type. This study intends to reveal the psychological problems that may develop due to the COVID-19 pandemic in DM, HT, and DM+HT patients and raise awareness. Methods: DM, HT, and DM+HT patients admitted to Internal Medicine Outpatient Clinic between 01.12.2020-01.02.2021, and healthy volunteers who accepted to participate were included in this prospective cross-sectional study. Patients who did not match the age range, had additional comorbidities besides DM and HT, were treated for psychiatric disease, or were pregnant, and those who did not give consent were excluded. After a psychiatric interview was performed, the participants were asked to fill in the Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Perceived Stress Scale (PSS), and Health Anxiety Scale (HAS). The effects of the COVID-19 pandemic on the frequency of admissions and perceived stress, health anxiety, general anxiety, and depression levels, and the change in stress burden experienced by disease type were examined. Results: There was a significant difference in all scales used between the patient groups and the healthy control group (HAS P<0.001, BDI P<0.001, BAI P=0.002, PSS P=0.001). There was a significant decrease in the frequency of admission to the outpatient clinics among DM + HT patients (P=0.002). The mean duration of disease was lower in individuals whose frequency of admission to the outpatient clinic decreased (P=0.006). Patients with a family history of COVID-19 had significant decreases in the frequency of admission to the outpatient clinic (P<0.001) and had significantly disrupted medical treatment (P=0.007). Conclusion:Patients with DM and HT, a short duration of chronic diseases, and history of COVID-19 infection in their families are more prone to be affected psychologically, and patients who are more psychologically affected refer less to the outpatient clinic. It is essential to continue treatment in consultation with psychiatry if DM and HT patients presenting to the outpatient clinic have one or more of these risk factors.

show abstract

Section: Discussionsupporting

confidence: 89%

Section: Discussionsupporting

confidence: 89%

See 1 more Smart Citation

Perceived stress level and health anxiety during COVID-19 pandemic period in patients with diabetes mellitus and hypertension: A prospective cross-sectional study

Bozkurt¹,

Gürsoy²,

Atay³

et al. 2021

Journal of Surgery and Medicine

View full text Add to dashboard Cite

show abstract

“…Our findings show positive associations between depression and lower SES (OR = 2.22; 95% CI = 1.51-3.26), good health status (OR = 3.17; 95% CI = 2.33-4.33), sleep disturbances (OR = 1.96; 95% CI = 1.46-2.64), asthma/respiratory problems (OR = 1.73; 95% CI = 1.23-2.43), and fear of COVID-19 re-infection (OR = 2.16; 95% CI = 1.58-2.97). Several previous studies in Bangladesh conducted during the COVID-19 pandemic reported that depression was associated with moderate/poor health status, sleep concerns, chronic diseases, smoking, and fear of COVID-19 re-infection [25,26,30,32,33,64]. Another study also suggested that lower family income (OR = 2.99, 95% CI = 1.11-8.05), persistent symptoms (OR = 2.63; 95% CI = 1.34-5.17), and poor social support (OR = 3.13; 95% CI = 1.34-7.30) were significantly associated with depression [65].…”

Section: Discussionmentioning

confidence: 99%

Treatment, Persistent Symptoms, and Depression in People Infected with COVID-19 in Bangladesh

Islam

Ferdous

Islam

et al. 2021

IJERPH

View full text Add to dashboard Cite

Background: Coronavirus disease (COVID-19) has affected people’s lives globally. While important research has been conducted, much remains to be known. In Bangladesh, initial treatment (self-administered, hospitalized), persistent COVID-19 symptoms (“long COVID-19”), and whether COVID-19 leads to changes in mental state, such as depressive symptoms, of people are not known. This study aimed to examine treatment, persistent symptoms, and depression in people who had been infected with COVID-19 in Bangladesh. Methods: A cross-sectional survey was conducted on 1002 individuals infected with COVID-19 (60% male; mean age = 34.7 ± 13.9; age range = 18–81 years), with data taken over a one-month period (11 September 2020 to 13 October 2020). A self-reported online questionnaire was used to collect data on socio-demographics, lifestyle, COVID-19 symptoms (during and beyond COVID-19), medication (over-the-counter or doctor-prescribed), and depression (assessed using the Patient Health Questionnaire (PHQ-9)). Results: Twenty-four percent of participants self-medicated with over-the-counter medicine when they were first diagnosed with COVID-19. Self-medication was higher among female vs. male respondents (29.6% vs. 20.2%, respectively, p = 0.002). A minority (20%) reported that they experienced persistent COVID-like symptoms after recovering from COVID-19. The most reported persistent symptoms were diarrhea (12.7%) and fatigue (11.5%). Forty-eight percent of participants were categorized as having moderate to severe depression. Based on multivariate regression analysis, depression during COVID-19 was positively associated with lower family income, poor health status, sleep disturbance, lack of physical activity, hypertension, asthma/respiratory problems, fear of COVID-19 re-infection, and persistent COVID-19 symptoms. Conclusions: The findings suggest a need for appropriate interventions for COVID-19 patients to promote physical and mental wellbeing.

show abstract

“…There have been recommendations from various government agencies (5,6) across the world advising people with asthma to be more cautious and self-isolate longer which affects their livelihood, mental health and quality of life. People with asthma were reported have a higher prevalence of anxiety and stress than non-asthma controls (7). A qualitative study in the United Kingdom among patients with respiratory disease including asthma reported that they were fearful of death if infected with COVID-19 and confused with the mixed messages on shielding they received (8).…”

Section: Introductionmentioning

confidence: 99%

Asthma and risk of infection, hospitalization, ICU admission and mortality from COVID-19: Systematic review and meta-analysis

et al. 2021

View full text Add to dashboard Cite

Objective: As COVID-19 spreads across the world, there are concerns that people with asthma are at a higher risk of acquiring the disease, or of poorer outcomes. This systematic review aimed to summarize evidence on the risk of infection, severe illness and death from COVID-19 in people with asthma. Data sources and study selection: A comprehensive search of electronic databases including preprint repositories and WHO COVID-19 database was conducted (until 26 May 2020). Studies reporting COVID-19 in people with asthma were included. For binary outcomes, we performed Sidik-Jonkman random effects meta-analysis. We explored quantitative heterogeneity by subgroup analyses, meta regression and evaluating the I 2 statistic. Results: Fifty-seven studies with an overall sample size of 587 280 were included. The prevalence of asthma among those infected with COVID-19 was 7.46% (95% CI = 6.25-8.67). Non-severe asthma was more common than severe asthma (9.61% vs. 4.13%). Pooled analysis showed a 14% risk ratio reduction in acquiring COVID-19 (95% CI = 0.80-0.94; p < 0.0001) and 13% reduction in hospitalization with COVID-19 (95% CI = 0.77-0.99, p = 0.03) for people with asthma compared with those without. There was no significant difference in the combined risk of requiring admission to ICU and/or receiving mechanical ventilation for people with asthma (RR = 0.87 95% CI = 0.94-1.37; p = 0.19) and risk of death from COVID-19 (RR = 0.87; 95% CI = 0.68-1.10; p = 0.25). Conclusion:The findings from this study suggest that the prevalence of people with asthma among COVID-19 patients is similar to the global prevalence of asthma. The overall findings suggest that people with asthma have a lower risk than those without asthma for acquiring COVID-19 and have similar clinical outcomes.

show abstract

Mental Health Outcomes of Adults With Comorbidity and Chronic Diseases During the Covid-19 Pandemic: A Matched Case-Control Study

Cited by 69 publications

References 31 publications

Perceived stress level and health anxiety during COVID-19 pandemic period in patients with diabetes mellitus and hypertension: A prospective cross-sectional study

Perceived stress level and health anxiety during COVID-19 pandemic period in patients with diabetes mellitus and hypertension: A prospective cross-sectional study

Treatment, Persistent Symptoms, and Depression in People Infected with COVID-19 in Bangladesh

Asthma and risk of infection, hospitalization, ICU admission and mortality from COVID-19: Systematic review and meta-analysis

Contact Info

Product

Resources

About